NCT05106569 is a clinical trial of Spirometry in Amyotrophic Lateral Sclerosis, sponsored by State University of New York - Upstate Medical University.

Who is sponsoring NCT05106569?

NCT05106569 is sponsored by State University of New York - Upstate Medical University.

What drugs are being tested in NCT05106569?

Interventions in NCT05106569: Spirometry.

What condition does NCT05106569 study?

NCT05106569 studies Amyotrophic Lateral Sclerosis.

Is NCT05106569 still recruiting?

NCT05106569 is currently status unknown. Last updated 13 June 2023.

Last reviewed 2023-06-13 · How we verify

NCT05106569

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Telespirometry in Amyotrophic Lateral Sclerosis (ALS)

Status unknown Last updated 13 June 2023

What this trial tests

trial testing Spirometry in Amyotrophic Lateral Sclerosis in 100 participants. Status unknown.

Timeline

28 April 2021

Primary endpoint
30 June 2024

30 December 2024

Quick facts

Lead sponsor	State University of New York - Upstate Medical University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	28 April 2021
Primary completion	30 June 2024
Estimated completion	30 December 2024
Sites	2 locations across United States

Drugs / interventions tested

Spirometry

Conditions studied

Amyotrophic Lateral Sclerosis — all drugs for Amyotrophic Lateral Sclerosis →

Sponsor

State University of New York - Upstate Medical University

Who can join

Adults 18 to 100, any sex, with Amyotrophic Lateral Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators seek to validate Slow Vital Capacity (SVC) measurement in seated and supine positions using conventional and portable spirometry.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Pilot Feasibility of Web-Based Implementation of Respiratory Therapist Supervised At-Home Telespirometry in Amyotrophic Lateral Sclerosis
Young EI, Wang D, Collins J, Meyer J, et al · · 2023 · DOI 10.20944/preprints202307.0051.v1

Verify or expand the search:

Other trials of Spirometry

Trials testing the same drug.

NCT07351916 — Remission in Adults With Mild-to-moderate Asthma in Thailand · recruiting
NCT07328035 — Remission in Adults With Severe Asthma in Thailand · recruiting
NCT07375433 — Heart Failure With Preserved Ejection Fraction in Patients With Сhronic Obstructive Pulmonary Disease: Clinical Course a · recruiting
NCT07253883 — A Study to Understand the Accuracy of a New Breathing Device Compared to Standard Testing for Asthma and COPD · not yet recruiting
NCT06626178 — Development of an Artificial Intelligence Model for the Identification and Prevention of Smoking-related Diseases. · NA · recruiting

Other recruiting trials for Amyotrophic Lateral Sclerosis

Currently open trials in the same condition.

NCT07502677 — Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral Scle · recruiting
NCT07478172 — Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease · NA · recruiting
NCT07204977 — Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS) · Phase 1 · active not recruiting
NCT07290062 — A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants · Phase 1 · recruiting
NCT07259980 — A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD- · recruiting

Other State University of New York - Upstate Medical University trials

Trials by the same sponsor.

NCT07220031 — Effect of Activated Charcoal on Serum Osmolality, Osmolal Gap, and Enzymatic Ethylene Glycol Assay · not yet recruiting
NCT04736953 — Sirolimus Treatment Of Patients With SLE · Phase 2 · not yet recruiting
NCT06045650 — Relationship Between Oxytocin Level, Trust, and Attachment in Individuals With Borderline Personality Disorder · not yet recruiting
NCT06370442 — Intranasal Dexmedetomidine vs. Standard of Care for Emergency Department (ED) Procedural Sedation in the Older Adult · Phase 3 · not yet recruiting
NCT05967455 — Homologous Re-infection With Dengue 1 or Dengue 3 · Phase 1 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05106569 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by State University of New York - Upstate Medical University
Last refreshed: 13 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05106569.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing